Associations Between Flavan-3-ol Intake and CVD Risk in the Norfolk Cohort of the European Prospective Investigation into Cancer (EPIC-Norfolk)

Overview

Journal Free Radic Biol Med

Specialties Biochemistry
Biology
General Medicine

Date 2015 Mar 22

PMID 25795512

Citations 16

Authors

Anna Vogiatzoglou

Angela A Mulligan

Amit Bhaniani

Marleen A H Lentjes

Alison McTaggart

Robert N Luben

Christian Heiss

Malte Kelm

Marc W Merx

Jeremy P E Spencer

Hagen Schroeter

Kay-Tee Khaw

Gunter G C Kuhnle

Affiliations

Soon will be listed here.

Abstract

Dietary intervention studies suggest that flavan-3-ol intake can improve vascular function and reduce the risk of cardiovascular diseases (CVD). However, results from prospective studies failed to show a consistent beneficial effect. Associations between flavan-3-ol intake and CVD risk in the Norfolk arm of the European Prospective Investigation into Cancer and Nutrition (EPIC-Norfolk) were investigated. Data were available from 24,885 (11,252 men; 13,633 women) participants, recruited between 1993 and 1997 into the EPIC-Norfolk study. Flavan-3-ol intake was assessed using 7-day food diaries and the FLAVIOLA Flavanol Food Composition database. Missing data for plasma cholesterol and vitamin C were imputed using multiple imputation. Associations between flavan-3-ol intake and blood pressure at baseline were determined using linear regression models. Associations with CVD risk were estimated using Cox regression analyses. Median intake of total flavan-3-ols was 1034mg/d (range: 0-8531mg/d) for men and 970mg/d (0-6695mg/d) for women, median intake of flavan-3-ol monomers was 233mg/d (0-3248mg/d) for men and 217 (0-2712mg/d) for women. There were no consistent associations between flavan-3-ol monomer intake and baseline systolic and diastolic blood pressure (BP). After 286,147 person-years of follow-up, there were 8463 cardiovascular events and 1987 CVD related deaths; no consistent association between flavan-3-ol intake and CVD risk (HR 0.93, 95% CI: 0.87; 1.00; Q1 vs Q5) or mortality was observed (HR 0.93, 95% CI: 0.84; 1.04). Flavan-3-ol intake in EPIC-Norfolk is not sufficient to achieve a statistically significant reduction in CVD risk.

Citing Articles

Reliance on self-reports and estimated food composition data in nutrition research introduces signiﬁcant bias that can only be addressed with biomarkers.

Ottaviani J, Sagi-Kiss V, Schroeter H, Kuhnle G Elife. 2024; 13.

PMID: 38896457 PMC: 11186626. DOI: 10.7554/eLife.92941.

Health Effects of Soy Isoflavones and Green Tea Catechins on Cancer and Cardiovascular Diseases Based on Urinary Biomarker Levels.

Ohishi T, Miyoshi N, Mori M, Sagara M, Yamori Y Molecules. 2022; 27(24).

PMID: 36558031 PMC: 9781513. DOI: 10.3390/molecules27248899.

Assessing Variability in Vascular Response to Cocoa With Personal Devices: A Series of Double-Blind Randomized Crossover n-of-1 Trials.

Bapir M, Campagnolo P, Rodriguez-Mateos A, Skene S, Heiss C Front Nutr. 2022; 9:886597.

PMID: 35769385 PMC: 9234529. DOI: 10.3389/fnut.2022.886597.

Integrated Multi-Omic Analyses of the Genomic Modifications by Gut Microbiome-Derived Metabolites of Epicatechin, 5-(4'-Hydroxyphenyl)-γ-Valerolactone, in TNFalpha-Stimulated Primary Human Brain Microvascular Endothelial Cells.

Corral-Jara K, Nuthikattu S, Rutledge J, Villablanca A, Morand C, Schroeter H Front Neurosci. 2021; 15:622640.

PMID: 33841078 PMC: 8033932. DOI: 10.3389/fnins.2021.622640.

Biomarker-estimated flavan-3-ol intake is associated with lower blood pressure in cross-sectional analysis in EPIC Norfolk.

Ottaviani J, Britten A, Lucarelli D, Luben R, Mulligan A, Lentjes M Sci Rep. 2020; 10(1):17964.

PMID: 33087825 PMC: 7578063. DOI: 10.1038/s41598-020-74863-7.

References

Sinha S, Myint P, Luben R, Khaw K . Accuracy of death certification and hospital record linkage for identification of incident stroke. BMC Med Res Methodol. 2008; 8:74. PMC: 2605452. DOI: 10.1186/1471-2288-8-74. View

Cassidy A, Rimm E, OReilly E, Logroscino G, Kay C, Chiuve S . Dietary flavonoids and risk of stroke in women. Stroke. 2012; 43(4):946-51. PMC: 3360888. DOI: 10.1161/STROKEAHA.111.637835. View

Khaw K, Bingham S, Welch A, Luben R, Wareham N, Oakes S . Relation between plasma ascorbic acid and mortality in men and women in EPIC-Norfolk prospective study: a prospective population study. European Prospective Investigation into Cancer and Nutrition. Lancet. 2001; 357(9257):657-63. DOI: 10.1016/s0140-6736(00)04128-3. View

Mulligan A, Kuhnle G, Lentjes M, van Scheltinga V, Powell N, McTaggart A . Intakes and sources of isoflavones, lignans, enterolignans, coumestrol and soya-containing foods in the Norfolk arm of the European Prospective Investigation into Cancer and Nutrition (EPIC-Norfolk), from 7 d food diaries, using a newly updated.... Public Health Nutr. 2012; 16(8):1454-62. PMC: 10271865. DOI: 10.1017/S1368980012003904. View

Ottaviani J, Momma T, Heiss C, Kwik-Uribe C, Schroeter H, Keen C . The stereochemical configuration of flavanols influences the level and metabolism of flavanols in humans and their biological activity in vivo. Free Radic Biol Med. 2010; 50(2):237-44. DOI: 10.1016/j.freeradbiomed.2010.11.005. View

Dillinger T, Barriga P, Escarcega S, Jimenez M, Salazar Lowe D, Grivetti L . Food of the gods: cure for humanity? A cultural history of the medicinal and ritual use of chocolate. J Nutr. 2000; 130(8S Suppl):2057S-72S. DOI: 10.1093/jn/130.8.2057S. View

Erlinger T, Vollmer W, Svetkey L, Appel L . The potential impact of nonpharmacologic population-wide blood pressure reduction on coronary heart disease events: pronounced benefits in African-Americans and hypertensives. Prev Med. 2003; 37(4):327-33. DOI: 10.1016/s0091-7435(03)00140-3. View

Knaze V, Zamora-Ros R, Lujan-Barroso L, Romieu I, Scalbert A, Slimani N . Intake estimation of total and individual flavan-3-ols, proanthocyanidins and theaflavins, their food sources and determinants in the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Br J Nutr. 2011; 108(6):1095-108. DOI: 10.1017/S0007114511006386. View

Vogiatzoglou A, Mulligan A, Luben R, Lentjes M, Heiss C, Kelm M . Assessment of the dietary intake of total flavan-3-ols, monomeric flavan-3-ols, proanthocyanidins and theaflavins in the European Union. Br J Nutr. 2013; 111(8):1463-73. DOI: 10.1017/S0007114513003930. View

10.

Ellinger S, Reusch A, Stehle P, Helfrich H . Epicatechin ingested via cocoa products reduces blood pressure in humans: a nonlinear regression model with a Bayesian approach. Am J Clin Nutr. 2012; 95(6):1365-77. DOI: 10.3945/ajcn.111.029330. View

11.

Ottaviani J, Kwik-Uribe C, Keen C, Schroeter H . Intake of dietary procyanidins does not contribute to the pool of circulating flavanols in humans. Am J Clin Nutr. 2012; 95(4):851-8. DOI: 10.3945/ajcn.111.028340. View

12.

Arts I, Jacobs Jr D, Harnack L, Gross M, Folsom A . Dietary catechins in relation to coronary heart disease death among postmenopausal women. Epidemiology. 2001; 12(6):668-75. DOI: 10.1097/00001648-200111000-00015. View

13.

Lupton J, Atkinson S, Chang N, Fraga C, Levy J, Messina M . Exploring the benefits and challenges of establishing a DRI-like process for bioactives. Eur J Nutr. 2014; 53 Suppl 1:1-9. PMC: 3991826. DOI: 10.1007/s00394-014-0666-3. View

14.

Hurst W, Krake S, Bergmeier S, Payne M, Miller K, Stuart D . Impact of fermentation, drying, roasting and Dutch processing on flavan-3-ol stereochemistry in cacao beans and cocoa ingredients. Chem Cent J. 2011; 5:53. PMC: 3215931. DOI: 10.1186/1752-153X-5-53. View

15.

DAgostino Sr R, Vasan R, Pencina M, Wolf P, Cobain M, Massaro J . General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation. 2008; 117(6):743-53. DOI: 10.1161/CIRCULATIONAHA.107.699579. View

16.

Wareham N, Jakes R, Rennie K, Mitchell J, Hennings S, Day N . Validity and repeatability of the EPIC-Norfolk Physical Activity Questionnaire. Int J Epidemiol. 2002; 31(1):168-74. DOI: 10.1093/ije/31.1.168. View

17.

Neveu V, Perez-Jimenez J, Vos F, Crespy V, du Chaffaut L, Mennen L . Phenol-Explorer: an online comprehensive database on polyphenol contents in foods. Database (Oxford). 2010; 2010:bap024. PMC: 2860900. DOI: 10.1093/database/bap024. View

18.

Mink P, Scrafford C, Barraj L, Harnack L, Hong C, Nettleton J . Flavonoid intake and cardiovascular disease mortality: a prospective study in postmenopausal women. Am J Clin Nutr. 2007; 85(3):895-909. DOI: 10.1093/ajcn/85.3.895. View

19.

Ottaviani J, Momma T, Kuhnle G, Keen C, Schroeter H . Structurally related (-)-epicatechin metabolites in humans: assessment using de novo chemically synthesized authentic standards. Free Radic Biol Med. 2012; 52(8):1403-12. DOI: 10.1016/j.freeradbiomed.2011.12.010. View

20.

Day N, Oakes S, Luben R, Khaw K, Bingham S, Welch A . EPIC-Norfolk: study design and characteristics of the cohort. European Prospective Investigation of Cancer. Br J Cancer. 1999; 80 Suppl 1:95-103. View